Gulati, K. ., Wijndaele, K. ., Webb, J. ., von Arx, L. B., Seif, M. ., Jennison, T. ., … Khunti, K. . (2025). Achievement of HbA1c and weight targets in adults with type 2 diabetes on once weekly injectable glucagon-like peptide-1 receptor agonist therapy in UK primary care: A retrospective, real-world study. Diabetes Obes Metab. http://doi.org/10.1111/dom.16201
L. von Arx
First name
L.
Middle name
B.
Last name
von Arx
Kleyn, C. E., McKenzie, R. ., Meeks, A. ., Gittens, B. ., & von Arx, L. B. (2023). Prevalence and treatment patterns of adult atopic dermatitis in the UK Clinical Practice Research Datalink. Skin Health Dis, 3, e232. http://doi.org/10.1002/ski2.232
von Arx, L. B., Rachman, J. ., Webb, J. ., Casey, C. ., Patel, A. ., Diomatari, C. ., … Idris, I. . (2023). Therapeutic inertia related to the injectable glucagon-like peptide-1 receptor agonists dulaglutide and semaglutide in patients with type 2 diabetes in UK primary care. Diabetes Obes Metab. http://doi.org/10.1111/dom.14985
Webb, J. ., Mount, J. ., von Arx, L. B., Rachman, J. ., Spanopoulos, D. ., Wood, R. ., … Idris, I. . (2021). Cardiovascular risk profiles: A cross-sectional study evaluating the generalisability of the glucagon-like peptide-1 receptor agonist cardiovascular outcome trials Rewind, Leader and Sustain-6 to the real-world type 2 diabetes population in the UK. Diabetes Obes Metab. http://doi.org/10.1111/dom.14580